Jagman,
Surely he can sell just ONE product to one customer!
I am shocked you have not heard of BSX. Rather large customer.
Biotechs can easily command billion dollar market caps long before they ever get to market. The path to market through regulatory authorities is a long and treacherous one but the rewards can more than compensate with a guaranteed monopoly enforced by the feds.
Why ignore the realities of the marketplace?
For now, Biophan's products are IP.
Intangibles are quite salable.
What price would you put on, say, just the name Coca-Cola, Jagman? Some have put a rather hefty price on it. The sugar and water product is rather cheap by comparison.
Best, Terry
News 
Market Data 
Discover 
